down arrow

Sun Pharma.Inds.

44
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,692.15
40.15 (2.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
48,496.00
43,885.00
38,654.00
33,498.00
32,837.00
29,065.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
48,496.00
43,885.00
38,654.00
33,498.00
32,837.00
29,065.00
Expenditure (Ex Depriciation)
Stock Adjustments
292.00
-686.00
-107.00
-638.00
300.00
-433.00
Raw Materials Consumed
10,370.00
11,349.00
10,459.00
9,328.00
8,929.00
8,302.00
Power & Fuel Cost
760.00
830.00
702.00
627.00
621.00
613.00
Employee Cost
9,429.00
8,296.00
7,300.00
6,862.00
6,362.00
5,967.00
Operating Expenses
2,186.00
1,936.00
1,880.00
1,723.00
1,690.00
1,884.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
5,780.00
5,226.00
4,096.00
3,103.00
3,654.00
2,621.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1,437.00
1,031.00
807.00
843.00
963.00
1,073.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
35,509.00
32,238.00
28,410.00
25,030.00
25,863.00
22,758.00
Operating Profit (PBDIT) excl Other Income
12,987.00
11,646.00
10,243.00
8,467.00
6,974.00
6,307.00
Other Income
1,390.00
634.00
1,075.00
859.00
651.00
1,025.00
Operating Profit (PBDIT)
14,377.00
12,281.00
11,319.00
9,326.00
7,625.00
7,333.00
Interest
238.00
172.00
127.00
141.00
302.00
555.00
Profit before Depriciation and Tax
14,138.00
12,109.00
11,191.00
9,185.00
7,323.00
6,777.00
Depreciation
2,556.00
2,529.00
2,143.00
2,079.00
2,052.00
1,753.00
Profit Before Taxation & Exceptional Items
11,582.00
9,579.00
9,048.00
7,105.00
5,270.00
5,024.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
11,087.00
9,408.00
4,481.00
2,799.00
5,009.00
3,810.00
Provision for Tax
1,439.00
847.00
1,075.00
514.00
822.00
600.00
Profit After Tax
9,648.00
8,560.00
3,405.00
2,284.00
4,186.00
3,209.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
43,610.00
37,645.00
36,598.00
35,320.00
33,330.00
31,977.00
Profit Available for appropriations
53,186.00
46,119.00
39,870.00
38,223.00
37,095.00
34,643.00
Appropriations
53,186.00
46,119.00
39,870.00
38,223.00
37,095.00
34,643.00
Equity Dividend (%)
1,350.00%
1,150.00%
1,000.00%
750.00%
400.00%
275.00%
Earnings Per Share
39.90
35.30
13.60
12.10
15.70
11.10
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 10.51% vs 13.53% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 11.51% vs 13.70% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 38.65% vs 35.06% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 12.70% vs 151.36% in Mar 2023

Compare Profit and Loss Results of Sun Pharma.Inds.
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
48,496.00
7,845.00
40,651.00
518.18%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
48,496.00
7,845.00
40,651.00
518.18%
Expenditure (Ex Depriciation)
Stock Adjustments
292.00
-109.00
401.00
367.89%
Raw Materials Consumed
10,370.00
3,238.00
7,132.00
220.26%
Power & Fuel Cost
760.00
477.00
283.00
59.33%
Employee Cost
9,429.00
1,094.00
8,335.00
761.88%
Operating Expenses
2,186.00
388.00
1,798.00
463.40%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5,780.00
90.00
5,690.00
6,322.22%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1,437.00
130.00
1,307.00
1,005.38%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
35,509.00
5,639.00
29,870.00
529.70%
Operating Profit (PBDIT) excl Other Income
12,987.00
2,206.00
10,781.00
488.71%
Other Income
1,390.00
339.00
1,051.00
310.03%
Operating Profit (PBDIT)
14,377.00
2,545.00
11,832.00
464.91%
Interest
238.00
4.00
234.00
5,850.00%
Profit before Depriciation and Tax
14,138.00
2,541.00
11,597.00
456.40%
Depreciation
2,556.00
378.00
2,178.00
576.19%
Profit Before Taxation & Exceptional Items
11,582.00
2,163.00
9,419.00
435.46%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11,087.00
2,163.00
8,924.00
412.58%
Provision for Tax
1,439.00
563.00
876.00
155.60%
Profit After Tax
9,648.00
1,600.00
8,048.00
503.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
43,610.00
10,959.00
32,651.00
297.94%
Profit Available for appropriations
53,186.00
12,559.00
40,627.00
323.49%
Appropriations
53,186.00
12,559.00
40,627.00
323.49%
Equity Dividend (%)
1350%
1500%
-150.00
Earnings Per Share
39.9
60.27
-20.37
-33.80%
Profit And Loss - Net Sales
Net Sales 48,496.85 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.51% vs 13.53% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12,987.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 11.51% vs 13.70% in Mar 2023

Profit And Loss - Interest
Interest 238.47 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 38.65% vs 35.06% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 9,648.44 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 12.70% vs 151.36% in Mar 2023